NCT02604498View on ClinicalTrials.gov

Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 14, 2016

Primary Completion Date

January 15, 2018

Study Completion Date

January 15, 2018

Conditions

Liver Dysfunction

Interventions

DRUG

Nemonoxacin

Single dose 500mg oral

Trial Locations (1)

20040

Huashan Hospital, Fudan University, Shanghai

All Listed Sponsors

collaborator

Huashan Hospital

OTHER

lead

Zhejiang Medicine Co., Ltd.

INDUSTRY

NCT02604498 - Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function | Biotech Hunter | Biotech Hunter